Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
Please note that all translations are automatically generated. Click here for the English version.
471 Views
•
08:15 min
•
May 10th, 2024
DOI :
May 10th, 2024
•1Graduate School, Hebei University of Chinese Medicine, 2School of Basic Medical Sciences, Hebei University of Chinese Medicine, 3Department of Endocrinology and Nephrology, Renal Research Institute of Beijing University of Chinese Medicine, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, 4Hebei Province Academy of Chinese Medicine Sciences, 5Department of Nephrology, First Affiliated Hospital, Hebei University of Chinese Medicine
Rozdziały w tym wideo
0:00
Introduction
1:06
Deciphering Jiawei Shengjiang San Action on Diabetic Nephropathy Using Network Pharmacology
Powiązane Filmy
08:43
Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
19.4K Views
09:26
The Monoiodoacetate Model of Osteoarthritis Pain in the Mouse
34.8K Views
08:42
A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics
8.6K Views
11:44
A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta
11.3K Views
08:31
Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction
10.1K Views
09:42
Isometric Contractility Measurement of the Mouse Mesenteric Artery Using Wire Myography
14.6K Views
07:34
Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
9.6K Views
06:29
Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation
3.8K Views
07:14
Acupuncture in a Rat Model of Asthma
5.9K Views
07:15
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
297 Views
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone